A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study

Clinical trial NCT02158546 · COMPLETED

Trial details

NCT number: NCT02158546
Sponsor: Alkermes, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2014-05-01
Primary completion: 2015-12-01
Enrollment: 447

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.